Form 4: National Healthcare Properties Director Receives Restricted Stock Grant Amidst No Established Market

National Healthcare Properties, Inc. Director Leslie D. Michelson was granted 3,110 restricted shares of common stock as part of the company's 2025 Omnibus Incentive Compensation Plan, which will vest on May 22, 2026.

Summary

• Leslie D. Michelson, a Director of National Healthcare Properties, Inc. (NHP), acquired 3,110 restricted shares of NHP common stock on May 23, 2025.
• These shares were issued under NHP's 2025 Omnibus Incentive Compensation Plan and are scheduled to vest on May 22, 2026.
• The acquisition price for these restricted shares was $0, indicating they are a compensation grant.
• Following this transaction, Mr. Michelson beneficially owns 95,971 shares of NHP common stock.
• The total shares beneficially owned reflect an adjustment for a four-for-one reverse stock split effected by NHP on September 30, 2024.
• NHP's board of directors approved an estimated per-share net asset value (NAV) of Common Stock of $32.15 as of December 31, 2024.
• There is currently no established market for NHP's Common Stock.

Sentiment

Score: 6

Explanation: The grant of restricted shares to a director is a positive for aligning interests, and the company provides an estimated NAV. However, the significant negative is the explicit statement that 'there is no established market for the Common Stock,' which implies severe illiquidity and lack of price discovery, tempering overall sentiment.

Positives

• The grant of 3,110 restricted shares to a director aligns management and director interests with long-term company performance.
• The shares are part of an "Omnibus Incentive Compensation Plan," suggesting a structured approach to executive and director compensation.
• The company's board has established an estimated Net Asset Value (NAV) of $32.15 per share, providing a valuation benchmark despite the lack of a public market.

Negatives

• There is no established market for the Common Stock, which significantly limits liquidity and price discovery for shareholders.
• The shares were acquired at a price of $0, indicating they are a compensation grant rather than a direct purchase, which does not signal direct confidence in a market price (as none exists).

Risks

• **Lack of Established Market**: The explicit statement that "There is no established market for the Common Stock" means shareholders may face significant challenges in selling their shares and determining their fair value.
• **Illiquidity**: The absence of a public market implies high illiquidity for the company's common stock, making it difficult for investors to exit their positions.
• **Valuation Uncertainty**: While an estimated NAV is provided, the lack of a public market means the actual realizable value of the shares could differ significantly and is not subject to market forces.

Future Outlook

The 3,110 restricted shares granted to Director Leslie D. Michelson are scheduled to vest on May 22, 2026, indicating a future milestone for this compensation.

Management Comments

• The board of directors of NHP approved an estimated per-share net asset value of Common Stock of $32.15 as of December 31, 2024.

Industry Context

This Form 4 filing details an insider transaction for National Healthcare Properties, Inc., a company operating without an established public market for its common stock. The grant of restricted shares is a common compensation practice in many industries, including healthcare real estate, to align director incentives with long-term company performance. The company's focus on healthcare properties suggests it operates within the real estate investment trust (REIT) sector, which typically involves stable, income-generating assets. The lack of a public market is unusual for a company filing with the SEC, suggesting it might be privately held or in a transitional phase, despite being subject to Section 16 reporting.

Comparison to Industry Standards

• The grant of restricted stock as part of an incentive compensation plan is a standard practice for director remuneration across various industries, including healthcare REITs.
• However, the absence of an established public market for the common stock is highly unusual for a company subject to SEC reporting requirements, making direct comparisons to publicly traded healthcare REITs like Welltower (WELL), Ventas (VTR), or Healthpeak Properties (PEAK) on metrics like liquidity, market capitalization, or trading volume impossible.
• The company's estimated NAV of $32.15 per share provides an internal valuation, but without a market, it cannot be directly compared to the market prices or NAVs of publicly traded peers.

Corporate Governance

Related Party Transactions

• The grant of 3,110 restricted shares to Leslie D. Michelson, a director of National Healthcare Properties, Inc., constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• **Shareholders**: The grant of restricted shares to a director aims to align their interests with shareholders, potentially encouraging long-term value creation. However, the lack of an established market for the common stock significantly impacts existing and potential shareholders' ability to trade or value their holdings.
• **Management/Directors**: Leslie D. Michelson directly benefits from the compensation, which vests in 2026, providing a future incentive.

Next Steps

• Vesting of the 3,110 restricted shares on May 22, 2026.

Key Dates

Keywords

National Healthcare Properties, NHP, Form 4, SEC Filing, Restricted Stock, Stock Grant, Director Compensation, Insider Ownership, Omnibus Incentive Plan, Net Asset Value, Reverse Stock Split, Healthcare Real Estate